Filing Flows › Zentalis Pharmaceuticals (ZNTL) › Who owns the stock
Who owns Zentalis Pharmaceuticals (ZNTL) stock
112 funds reported Zentalis Pharmaceuticals (ZNTL) shares in their latest 13F filings, worth $230M in all. The largest holder is 5AM Venture Management, LLC ($19.1M). Last quarter 56 funds added to their stakes and 47 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| 5AM Venture Management, LLC | 3,947,913 | $19.1M | unchanged | 2026-06-30 |
| BlackRock | 3,753,525 | $18.2M | increase | 2026-06-30 |
| Squadron Capital Management LLC | 3,700,000 | $17.9M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 3,024,936 | $14.7M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,835,669 | $13.8M | increase | 2026-06-30 |
| Acadian Asset Management LLC | 2,681,900 | $13.0M | decrease | 2026-06-30 |
| Citadel Advisors LLC | 2,298,403 | $11.1M | increase | 2026-06-30 |
| Renaissance Technologies LLC | 1,609,078 | $7.8M | decrease | 2026-06-30 |
| Opaleye Management | 1,412,656 | $6.9M | unchanged | 2026-06-30 |
| Orbimed Advisors LLC | 1,390,576 | $6.7M | new | 2026-06-30 |
| Decheng Capital LLC | 1,323,327 | $6.4M | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 1,284,117 | $6.2M | increase | 2026-06-30 |
| Bank of America | 1,114,650 | $5.4M | decrease | 2026-06-30 |
| Ishara Investments LP | 1,025,000 | $5.0M | decrease | 2026-06-30 |
| Primecap Management | 957,420 | $4.6M | unchanged | 2026-06-30 |
Zentalis Pharmaceuticals' latest quarter
Zentalis Pharmaceuticals, Q4 2024: revenue $26.9M, operating margin -185.6%, net loss $47.5M, operating cash flow −$39.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ZNTL stock?
By the latest 13F filings: 5AM Venture Management, LLC ($19.1M); BlackRock ($18.2M); Squadron Capital Management LLC ($17.9M); Two Sigma Investments, LP ($14.7M); Vanguard Capital Management LLC ($13.8M).
What is the short interest in ZNTL?
5,986,678 shares were sold short at the 2026-10-15 settlement, 0.49% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.